Efficacy and safety of a newly developed polylactic acid microsphere as an injectable bulking agent for penile augmentation

18-months follow-up

D. Y. Yang, K. Ko, S. H. Lee, Du Geon Moon, J. W. Kim, W. K. Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Polylactic acid (PLA) fillers are widely used for cosmetic volume augmentation. But, no study has evaluated the use of PLA filler in penile augmentation (PA No. 4). We evaluated the efficacy and safety of a newly developed PLA filler for PA during a 18-month follow-up period. A total of 23 healthy adult men were prospectively enrolled between June and November 2012. Penile girth was measured at proximal-, mid- A nd distal-shaft at baseline, 3, 6, 12 and 18 months following injection. Subjects' satisfaction was assessed with visual analogue scale (VAS). Adverse events (AEs) were also reported. Mean injected volume was 20 ml. The circumference of proximal-, mid-, and distal-shaft increased by a mean of 2.2 ± 0.2, 2.7 ± 1.0 and 2.7 ± 1.0 cm at 3 months, respectively (each P<0.001). No significant differences were noted in girth circumference between 3 and 18 months post-injection (each P>0.05). VAS score increased from 51.6 ± 14.7 at baseline to 64.8 ± 19.3 and 74.3 ± 14.6 at 3 and 6 months, respectively (each P<0.05). Six cases of mild, transient treatment-emergent AEs were reported in 5 subjects. Serious AEs were not reported. In conclusion, penile injection of a newly developed PLA filler led to significant penile augmentative effects for up to 18 months and was well tolerated without serious AEs.

Original languageEnglish
Pages (from-to)136-141
Number of pages6
JournalInternational Journal of Impotence Research
Volume29
Issue number4
DOIs
Publication statusPublished - 2017 Jul 1

Fingerprint

Microspheres
Safety
Injections
Visual Analog Scale
Cosmetics
poly(lactic acid)
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Efficacy and safety of a newly developed polylactic acid microsphere as an injectable bulking agent for penile augmentation : 18-months follow-up. / Yang, D. Y.; Ko, K.; Lee, S. H.; Moon, Du Geon; Kim, J. W.; Lee, W. K.

In: International Journal of Impotence Research, Vol. 29, No. 4, 01.07.2017, p. 136-141.

Research output: Contribution to journalArticle

@article{4e9375dc51c14d3fa593cf1c4c6e457e,
title = "Efficacy and safety of a newly developed polylactic acid microsphere as an injectable bulking agent for penile augmentation: 18-months follow-up",
abstract = "Polylactic acid (PLA) fillers are widely used for cosmetic volume augmentation. But, no study has evaluated the use of PLA filler in penile augmentation (PA No. 4). We evaluated the efficacy and safety of a newly developed PLA filler for PA during a 18-month follow-up period. A total of 23 healthy adult men were prospectively enrolled between June and November 2012. Penile girth was measured at proximal-, mid- A nd distal-shaft at baseline, 3, 6, 12 and 18 months following injection. Subjects' satisfaction was assessed with visual analogue scale (VAS). Adverse events (AEs) were also reported. Mean injected volume was 20 ml. The circumference of proximal-, mid-, and distal-shaft increased by a mean of 2.2 ± 0.2, 2.7 ± 1.0 and 2.7 ± 1.0 cm at 3 months, respectively (each P<0.001). No significant differences were noted in girth circumference between 3 and 18 months post-injection (each P>0.05). VAS score increased from 51.6 ± 14.7 at baseline to 64.8 ± 19.3 and 74.3 ± 14.6 at 3 and 6 months, respectively (each P<0.05). Six cases of mild, transient treatment-emergent AEs were reported in 5 subjects. Serious AEs were not reported. In conclusion, penile injection of a newly developed PLA filler led to significant penile augmentative effects for up to 18 months and was well tolerated without serious AEs.",
author = "Yang, {D. Y.} and K. Ko and Lee, {S. H.} and Moon, {Du Geon} and Kim, {J. W.} and Lee, {W. K.}",
year = "2017",
month = "7",
day = "1",
doi = "10.1038/ijir.2017.10",
language = "English",
volume = "29",
pages = "136--141",
journal = "International Journal of Impotence Research",
issn = "0955-9930",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Efficacy and safety of a newly developed polylactic acid microsphere as an injectable bulking agent for penile augmentation

T2 - 18-months follow-up

AU - Yang, D. Y.

AU - Ko, K.

AU - Lee, S. H.

AU - Moon, Du Geon

AU - Kim, J. W.

AU - Lee, W. K.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Polylactic acid (PLA) fillers are widely used for cosmetic volume augmentation. But, no study has evaluated the use of PLA filler in penile augmentation (PA No. 4). We evaluated the efficacy and safety of a newly developed PLA filler for PA during a 18-month follow-up period. A total of 23 healthy adult men were prospectively enrolled between June and November 2012. Penile girth was measured at proximal-, mid- A nd distal-shaft at baseline, 3, 6, 12 and 18 months following injection. Subjects' satisfaction was assessed with visual analogue scale (VAS). Adverse events (AEs) were also reported. Mean injected volume was 20 ml. The circumference of proximal-, mid-, and distal-shaft increased by a mean of 2.2 ± 0.2, 2.7 ± 1.0 and 2.7 ± 1.0 cm at 3 months, respectively (each P<0.001). No significant differences were noted in girth circumference between 3 and 18 months post-injection (each P>0.05). VAS score increased from 51.6 ± 14.7 at baseline to 64.8 ± 19.3 and 74.3 ± 14.6 at 3 and 6 months, respectively (each P<0.05). Six cases of mild, transient treatment-emergent AEs were reported in 5 subjects. Serious AEs were not reported. In conclusion, penile injection of a newly developed PLA filler led to significant penile augmentative effects for up to 18 months and was well tolerated without serious AEs.

AB - Polylactic acid (PLA) fillers are widely used for cosmetic volume augmentation. But, no study has evaluated the use of PLA filler in penile augmentation (PA No. 4). We evaluated the efficacy and safety of a newly developed PLA filler for PA during a 18-month follow-up period. A total of 23 healthy adult men were prospectively enrolled between June and November 2012. Penile girth was measured at proximal-, mid- A nd distal-shaft at baseline, 3, 6, 12 and 18 months following injection. Subjects' satisfaction was assessed with visual analogue scale (VAS). Adverse events (AEs) were also reported. Mean injected volume was 20 ml. The circumference of proximal-, mid-, and distal-shaft increased by a mean of 2.2 ± 0.2, 2.7 ± 1.0 and 2.7 ± 1.0 cm at 3 months, respectively (each P<0.001). No significant differences were noted in girth circumference between 3 and 18 months post-injection (each P>0.05). VAS score increased from 51.6 ± 14.7 at baseline to 64.8 ± 19.3 and 74.3 ± 14.6 at 3 and 6 months, respectively (each P<0.05). Six cases of mild, transient treatment-emergent AEs were reported in 5 subjects. Serious AEs were not reported. In conclusion, penile injection of a newly developed PLA filler led to significant penile augmentative effects for up to 18 months and was well tolerated without serious AEs.

UR - http://www.scopus.com/inward/record.url?scp=85027007966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027007966&partnerID=8YFLogxK

U2 - 10.1038/ijir.2017.10

DO - 10.1038/ijir.2017.10

M3 - Article

VL - 29

SP - 136

EP - 141

JO - International Journal of Impotence Research

JF - International Journal of Impotence Research

SN - 0955-9930

IS - 4

ER -